健康元：健康元药业集团股份有限公司2020年社会责任报告（英文版）.PDF

1、For the health for the future(I)Group Overview 6(II)Organizational Structure 6(III)Corporate Culture 7(IV)Value Sharing 7(V)Our Awards 8The Report at A Glance 4Chairmans Statement 5About JoincareContents(I)CSR Strategy 9(II)CSR Governance 9(III)Communication on Responsibilities 101.Communication wit

2、h Stakeholders 102.Decision of Critical Issues 11(IV)Compliance Governance 121.Protection of Shareholders Rights and Interests 122.Performance of Duties of Directors and Supervisors 123.Disclosure Transparency 124.Carrying Forward the Party-Masses Spirit 13(V)Integrity and Business Ethics 141.Establ

3、ishing the Polices of Business Ethics 142.Internal Audit and Supervision 153.Whistleblower Protection 154.Promoting a Culture of Integrity 15CSR Governance01(I)Focusing on R&D and Innovation 161.Committed to Respiratory Healthcare Market Niche 182.R&DEffortsinBio-PharmaMarket203.Planning in Long-act

4、ing sustained-release microspheres 214.Setup of Nano-lipid Microemulsion R&D Platform 215.Paying Attention to Rare Diseases 226.Protecting Intellectual Property Rights 237.Promoting Industrial Development 24(II)Improving the Accessibility of Medicines 251.Improving Healthcare Accessibility 252.Impro

5、vingMedicalAffordability263.Advocating for the Rational Use of Medicines 26Inclusive Healthcare02(I)Protection of Rights and Interests of Employees 381.Compliance of the labor Law 382.Workface Diversity and Inclusiveness 383.Openness to Communication 39(II)Human Resources Management 391.Talent Recru

6、iting and Retention 392.Compensation System 393.Equity Incentive Compensation 404.Training and Development 405.Training and Promotion Plans 416.Encourage Work-Life Balance 42Health Empowerment04(I)Product Quality Control Mechanism 271.Managing Quality System 272.Quality Risk Management 293.Pharmacov